Orexo: Zubsolv Rx data

Research Update

2018-10-05

11:27

Zubsolv market share was unchanged in September compared August, and was at 5.1% (Rx) and 5.6% (quantity), according to the latest data from Symphony Health Solutions which was released today.

KP

Klas Palin

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.